Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 10, 2016, Pages 1439-1444

  Peyrin Biroulet, Laurent ^a,b   Harmsen, W Scott ^a   Tremaine, William J ^a   Zinsmeister, Alan R ^a   Sandborn, William J ^a,c   Loftus, Edward V ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bowel Damage; IBD; Outcome; Progression; Surgery

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; COLON RESECTION; CROHN DISEASE; CUMULATIVE LENGTH OF BOWEL RESECTION; DIGESTIVE TRACT PARAMETERS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINNESOTA; OUTCOME ASSESSMENT; PATIENT INFORMATION; POPULATION RESEARCH; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL PATIENT; ABDOMINAL SURGERY; AGED; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84991037804     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.04.031     Document Type: Article

References (31)

1. 1 Peyrin-Biroulet, L., Loftus, E.V. Jr., Colombel, J.F., et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 105 (2010), 289–297.
2. 2 Thia, K.T., Sandborn, W.J., Harmsen, W.S., et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 139 (2010), 1147–1155.
3. 3 Bernstein, C.N., Loftus, E.V. Jr., Ng, S.C., et al. Hospitalisations and surgery in Crohn's disease. Gut 61 (2012), 622–629.
4. 4 Peyrin-Biroulet, L., Harmsen, W.S., Tremaine, W.J., et al. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol 107 (2012), 1693–1701.
5. 5 Buisson, A., Chevaux, J.B., Allen, P.B., et al. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 35 (2012), 625–633.
6. 6 Sharp, J.T., Radiographic evaluation of the course of articular disease. Clin Rheum Dis 9 (1983), 541–557.
7. 7 Pariente, B., Cosnes, J., Danese, S., et al. Development of the Crohn's disease digestive damage score, the Lemann score. Inflamm Bowel Dis 17 (2011), 1415–1422.
8. 8 Pariente, B., Mary, J.Y., Danese, S., et al. Development of the Lémann Index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology 148 (2015), 52–63.
9. 9 Cosnes, J., de Parades, V., Carbonnel, F., et al. Classification of the sequelae of bowel resection for Crohn's disease. Br J Surg 81 (1994), 1627–1631.
10. 10 Peyrin-Biroulet, L., Gueant-Rodriguez, R.M., Chen, M., et al. Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease. Am J Gastroenterol 103 (2008), 399–406.
11. 11 Klaus, J., Spaniol, U., Adler, G., et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's disease. BMC Gastroenterol, 9, 2009, 61.
12. 12 Spiller, R.C., Trotman, I.F., Higgins, B.E., et al. The ileal brake: inhibition of jejunal motility after ileal fat perfusion in man. Gut 25 (1984), 365–374.
13. 13 St Sauver, J.L., Grossardt, B.R., Leibson, C.L., et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 87 (2012), 151–160.
14. 14 Rocca, W.A., Yawn, B.P., St Sauver, J.L., et al. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 87 (2012), 1202–1213.
15. 15 St Sauver, J.L., Grossardt, B.R., Yawn, B.P., et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 41 (2012), 1614–1624.
16. 16 St Sauver, J.L., Grossardt, B.R., Yawn, B.P., et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 173 (2011), 1059–1068.
17. 17 Loftus, E.V. Jr., Silverstein, M.D., Sandborn, W.J., et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114 (1998), 1161–1168.
18. 18 Loftus, C.G., Loftus, E.V. Jr., Harmsen, W.S., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 13 (2007), 254–261.
19. 19 Ingle, S.B., Loftus, E.V., Tremaine, W.J., et al. Increasing incidence and prevalence of inflammatory bowel disease in Olmsted County, Minnesota, 2001-2004 [abstract]. Gastroenterology 132:Suppl 2 (2007), A19–A20.
20. 20 Silverberg, M.S., Satsangi, J., Ahmad, T., et al. Toward an integrated clinical molecular and serological classification of inflammatory bowel disease: report of a working party of the Montreal World Congress of Gastroenterology. Can J Gastroenterol 19:Suppl A (2005), 5A–36A.
21. 21 Allen, P.B., Peyrin-Biroulet, L., Moving towards disease modification in inflammatory bowel disease therapy. Curr Opin Gastroenterol 29 (2013), 397–404.
22. 22 Colombel, J.F., Sandborn, W.J., Rutgeerts, P., et al. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial. Am J Gastroenterol 104 (2009), 1170–1179.
23. 23 Feagan, B.G., Panaccione, R., Sandborn, W.J., et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 135 (2008), 1493–1499.
24. 24 Rungoe, C., Langholz, E., Andersson, M., et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 63 (2014), 1607–1616.
25. 25 Uchino, M., Ikeuchi, H., Bando, T., et al. Risk factors for short bowel syndrome in patients with Crohn's disease. Surg Today 42 (2012), 447–452.
26. 26 Yadav, S., Edakkanambeth Varayil, J., Harmsen, S., et al. Incidence and outcomes of home parenteral nutrition in patients with Crohn's disease in Olmsted County, Minnesota (abstract). Am J Gastroenterol, 109(Suppl), 2014, S506.
27. 27 Ramadas, A.V., Gunesh, S., Thomas, G.A., et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 59 (2010), 1200–1206.
28. 28 Peyrin-Biroulet, L., Cieza, A., Sandborn, W.J., et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61 (2012), 241–247.
29. 29 Agrez, M.V., Valente, R.M., Pierce, W., et al. Surgical history of Crohn's disease in a well-defined population. Mayo Clin Proc 57 (1982), 747–752.
30. 30 Peyrin-Biroulet, L., Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature. Am J Gastroenterol 108 (2013), 859–860.
31. 31 Peyrin-Biroulet, L., Oussalah, A., Williet, N., et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 60 (2011), 930–936.